Experiment 1072292

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismCatharanthus roseus (APOCYNACEAE)
CitationSKLAROFF,RB: ARLIN,Z: YOUNG,CW:. (1979). PHASE II TRIAL OF VINDESINE IN PATIENTS WITH ACUTE LEUKEMIA.. 63()
Amount utilized
Compound isolated
DiseaseA PHASE II TRIAL IN 18 PATIENTS WITH ACUTE LEUKEMIA WHO HAD FAILED CONVENTIONAL CHEMOTHERAPY DOSING WAS BY IV BOLUS INFUSION DAILY X 5-10 DAYS SIGNIFICANT HEMATOLOGIC TOXICITY 2/13 PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA HAD PARTIAL REMISSIONS (LASTING 2-3 MONTHS) AND 5/13 HAD MINOR RESPONSES
Dose amount1-2.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES